Sun, Y. , Cheng, X. and Pen, K. (2024) Clinical Value of Platelet-Related Parameters and Monocyte Counts in Patients with ...

CD40L inhibitor dapirolizumab pegol significantly reduced disease activity and corticosteroid use in patients with SLE in the PHOENYCS GO trial.

ACR 2024 highlighted new guidelines for the screening, treatment, and management of lupus nephritis, stressing prompt kidney biopsy and timely treatment.

Study reveals that achieving low disease activity or remission in lupus patients with high disease activity reduces organ ...

Sunshine Lake Pharma Co Ltd. has divulged non-receptor tyrosine-protein kinase TYK2 inhibitors reported to be useful for the treatment of multiple sclerosis, psoriasis, rheumatoid arthritis, atopic ...

ESK-001 is a small molecule commercialized by Alumis, with a leading Phase III program in Plaque Psoriasis (Psoriasis Vulgaris).

The company is developing rezpegaldesleukin, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of ...

Yes, lupus can affect your voice. Lupus can cause inflammation and tissue damage, leading to hoarseness, vocal fatigue, and ...

Lupus and menopause can interact in complex ways, with menopause sometimes worsening lupus symptoms or, in other cases, ...

A considerable percentage of patients with SLE experienced delayed access to specialized care, which was associated with organ damage accrual.

For patients with systemic lupus erythematosus (SLE), neuropsychiatric (NP) symptoms can first present at any stage.

Years of translational research have successfully improved treatment outcomes for common dermatological conditions such as ... Lichen Sclerosus et Atrophicus, Vulvar Lichen Sclerosus, Lupus ...